Brexpiprazole for the treatment of agitation associated with dementia due to Alzheimer's disease: A 12-week, active-treatment, extension trial

Authors

Uwa Kalu
Denise Chang
Alpesh Shah (ORCID: https://orcid.org/0000-0002-8600-6352)
Dalei Chen
M Słomkowski (ORCID: https://orcid.org/0000-0001-7309-0914)
Nanco Hefting (ORCID: https://orcid.org/0000-0003-3310-3439)
Alvin Estilo
Daniel J. Lee (ORCID: https://orcid.org/0000-0002-6990-4441)
Mary Hobart
Saloni Behl

Institutions

Lundbeck (Denmark) (DK)
Otsuka (United States) (US)
Otsuka Pharmaceutical (Spain) (ES)
Lundbeck (United States) (US)

Publication Details

Journal: Journal of Alzheimer s Disease
Published: 2024-11-01
DOI: https://doi.org/10.3233/jad-240491
Citations: 10
Primary Topic: Schizophrenia research and treatment
Type: article
Field-Weighted Citation Impact: 3.86

Funders

H. Lundbeck A/S
Otsuka Pharmaceutical Development and Commercialization

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Brexpiprazole for the treatment of agitation associated with dementia due to Alzheimer's disease: A 12-week, active-treatment, extension trial

Uwa Kalu, Denise Chang, Alpesh Shah, Dalei Chen et al.

Nov 1, 2024

10 citations

Journal of Alzheimer s Disease

Schizophrenia research and treatment

3.86

article

Brexpiprazole for the treatment of agitation associated with dementia due to Alzheimer's disease: A 12-week, active-treatment, extension trial

Uwa Kalu, Denise Chang, Alpesh Shah, Dalei Chen, M Słomkowski, Nanco Hefting, Alvin Estilo, Daniel J. Lee, Mary Hobart, Saloni Behl

November 1, 2024article en

10 citations

Abstract

No abstract available for this paper.

Journal of Alzheimer s DiseaseVol. 102(2)

Lundbeck (Denmark) (DK), Otsuka (United States) (US), Otsuka Pharmaceutical (Spain) (ES), Lundbeck (United States) (US)

H. Lundbeck A/S, Otsuka Pharmaceutical Development and Commercialization

Good health and well-being

Openalex Percentile: Top 5%

Schizophrenia research and treatment

3.86

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Brexpiprazole for the treatment of agitation associated with dementia due to Alzheimer's disease: A 12-week, active-treatment, extension trial — Uwa Kalu, Denise Chang, et al. · Journal of Alzheimer s Disease (2024) | TGRS Research Map | TGRS